Mitochondrial-Derived Peptide Research

Humanin Reconstitution & BAC Water Research Guide

Humanin is a small mitochondria-derived peptide encoded within the mitochondrial genome and studied for its roles in cellular stress signaling, apoptosis, metabolism, and neuroprotection. Current evidence includes extensive laboratory and animal research plus observational human research, but it does not establish a universal therapeutic Humanin dose or a standardized BAC-water reconstitution protocol.

● Research compound ◆ Mitochondrial-derived peptide ! No FDA-approved Humanin indication identified
Simplified Humanin mitochondrial research illustration Decorative scientific illustration showing a mitochondrion, mitochondrial DNA and a highlighted Humanin peptide signal. mtDNA / MT-RNR2 HUMANIN mitochondrial signaling research Simplified research illustration — not a molecular structure
Humanin is a mitochondria-derived signaling peptide associated with cellular stress and survival research.
Research Snapshot
Compound Humanin
Compound Class Mitochondria-derived peptide
Research Category Mitochondrial & cellular signaling
Regulatory Status No FDA-approved indication identified
Human Evidence Observational / biomarker research
Vial Quantities No authoritative standard identified
Last Reviewed September 10, 2026

How Much BAC Water for Humanin?

There is no scientifically established universal BAC-water volume for Humanin. The appropriate mathematical volume depends on the total amount of peptide represented by the vial and the target concentration being used in a specific research protocol.

Adding more liquid produces a lower concentration; adding less liquid produces a higher concentration. The total quantity of Humanin in the vial does not change simply because the liquid volume changes.

Concentration = Total Vial Quantity ÷ Liquid Volume
Important distinction: The examples below are mathematical concentration calculations. They are not Humanin dosing instructions, manufacturer reconstitution directions, FDA-approved dosages, or BacScience recommendations.

Humanin Concentration Examples

No authoritative source reviewed for this page establishes a standardized commercial Humanin vial quantity. The following 5 mg and 10 mg quantities are therefore presented solely as calculation examples.

Hypothetical Vial Quantity 1 mL 2 mL 2.5 mL 3 mL 5 mL
5 mg 5 mg/mL 2.5 mg/mL 2 mg/mL 1.67 mg/mL 1 mg/mL
10 mg 10 mg/mL 5 mg/mL 4 mg/mL 3.33 mg/mL 2 mg/mL

How Much BAC Water Should Be Added to a Humanin Vial?

The scientifically defensible answer is that there is no single universal volume. First identify the actual peptide quantity stated on the vial, certificate of analysis, or applicable product documentation. Then determine the concentration mathematically from the selected liquid volume.

Key principle: Reconstitution volume and experimental dose are different variables. A research study reporting a dose does not automatically establish how a particular vial should be reconstituted.

How Much BAC Water for 5 mg Humanin?

If a hypothetical vial contained 5 mg of Humanin, the resulting concentration would depend on the liquid volume. For example, 1 mL would mathematically produce 5 mg/mL, while 2 mL would produce 2.5 mg/mL and 5 mL would produce 1 mg/mL.

How Much BAC Water for 10 mg Humanin?

For a hypothetical 10 mg quantity, 1 mL corresponds mathematically to 10 mg/mL, 2 mL to 5 mg/mL, 2.5 mL to 4 mg/mL, 3 mL to approximately 3.33 mg/mL, and 5 mL to 2 mg/mL.

How Does BAC-Water Volume Change Humanin Concentration?

For a fixed peptide quantity, concentration is inversely related to liquid volume. Doubling the liquid volume halves the concentration, while halving the liquid volume doubles the concentration.

How Do You Calculate Humanin Concentration?

Divide the total Humanin quantity by the final liquid volume:

mg/mL = mg of Humanin ÷ mL of liquid

Example: 5 mg ÷ 2 mL = 2.5 mg/mL.

Humanin and Mitochondrial Signaling

Humanin is part of the mitochondrial-derived peptide family. Reviews describe it as a small peptide encoded from the mitochondrial genome and associated with signaling pathways involved in cellular survival, stress responses, apoptosis, metabolism, and neuroprotection.

Research has examined both intracellular and extracellular actions. Proposed signaling mechanisms include interactions with apoptosis-related proteins and receptor-associated signaling involving pathways such as STAT3, ERK and AKT.

Evidence boundary: Mechanistic findings from cell and animal models should not be interpreted as proof of therapeutic benefit in humans.
Simplified Humanin cellular signaling research pathway Diagram showing mitochondrial stress, Humanin signaling, receptor-associated pathways, and cellular response. Simplified Humanin Signaling Schematic MITOCHONDRIA mtDNA / cellular stress HUMANIN mitochondrial-derived peptide PROPOSED / STUDIED SIGNALING receptor-associated signaling STAT3 • ERK • AKT • apoptosis-related pathways RESEARCHED CELLULAR RESPONSES stress response • survival • metabolism • apoptosis Simplified research schematic — pathways remain under investigation

Research schematic only; it does not represent a confirmed therapeutic mechanism or treatment pathway.

What Is Humanin?

Humanin is a small mitochondria-derived peptide. The canonical Humanin sequence is generally described as a 24-amino-acid peptide encoded within the mitochondrial 16S ribosomal RNA region MT-RNR2. Humanin was initially identified in research investigating neuroprotective activity associated with Alzheimer's-disease-related cellular stress.

Humanin subsequently became a prototype member of the mitochondrial- derived peptide family, alongside small humanin-like peptides and MOTS-c. Research has expanded into mitochondrial signaling, apoptosis, metabolism, cardiovascular biology, neurobiology and cellular stress responses.

Entity definition: Humanin is an endogenous mitochondrial-derived signaling peptide, not an FDA-approved drug with an established therapeutic indication.

How Humanin Works

Humanin biology is complex and remains under investigation. Published literature describes both intracellular and extracellular actions, with experimental evidence linking Humanin to pathways involved in cell survival, mitochondrial function, oxidative stress and apoptosis.

Intracellular research

  • Studies have examined Humanin interactions with apoptosis-associated proteins.
  • Experimental work has investigated effects on mitochondrial stress and cellular survival.
  • Humanin has been associated with regulation of metabolic and stress-response signaling.

Extracellular research

  • Humanin can function as a signaling peptide outside cells.
  • Receptor-associated pathways have been investigated in experimental systems.
  • Proposed downstream pathways include STAT3, ERK and AKT signaling.

What Is Humanin Being Studied For?

Humanin research spans several biological areas. The strength of evidence varies substantially between these areas, and most intervention findings come from laboratory or animal models.

Neuroprotection Studied in cellular and animal models involving neuronal stress and neurodegenerative disease mechanisms.
Metabolic Research Investigated in glucose regulation, insulin sensitivity and metabolic stress models.
Mitochondrial Biology Studied as part of mitochondrial-derived signaling and cellular stress responses.
Cardiovascular Research Investigated in vascular, cardiac and ischemia/reperfusion experimental models.
Evidence boundary: These research areas should not be interpreted as FDA-approved indications or established clinical treatments.
Human observational evidence

Human Clinical Research

Humanin has been measured in human blood and tissue in observational and biomarker studies, and human research has examined relationships between Humanin levels, metabolic status, exercise, cardiovascular function and other biological variables.

For example, published research has reported circulating Humanin associations with impaired fasting glucose, while exercise studies have investigated changes in skeletal-muscle or circulating Humanin. These studies measure endogenous Humanin and should not be confused with controlled therapeutic administration of synthetic Humanin.

ClinicalTrials.gov also contains observational studies involving Humanin measurements, including studies examining Humanin isoforms in cardiac tissue and plasma and the clinical value of plasma Humanin in acute kidney injury.

Human-dose statement: No clinically established human therapeutic dose for Humanin has been identified in the authoritative sources reviewed for this page.

Doses Studied in Published Research

Important: This section does not provide Humanin dosing recommendations. The evidence base includes experimental administration of Humanin analogues in animals and mechanistic research rather than an established human therapeutic dosing protocol.
Study Population / Model Dose Studied Route Frequency Duration Key Finding
Humanin metabolic research Rodent models Experimental Humanin / Humanin analogue protocols Experimental Study-specific Study-specific Experimental work has investigated insulin sensitivity and metabolic signaling.
Humanin lifespan / healthspan research C. elegans and mice HNG / Humanin analogue protocols Experimental Study-specific Study-specific Humanin analogue treatment produced biological effects in animal models, including metabolic and inflammatory endpoints.
Humanin cardiovascular models Rodent ischemia/reperfusion models HNG experimental dose Experimental Protocol-specific Acute experimental model Humanin analogue research has investigated mitochondrial dysfunction and cardioprotection.
Human observational research Human participants No administered Humanin dose Observation / sampling Study-specific Study-specific Studies have measured endogenous Humanin levels rather than establishing a therapeutic administered dose.

Because Humanin administration protocols in animal studies and Humanin biomarker measurements in humans are not equivalent, experimental doses should not be converted into human treatment recommendations.

Preclinical evidence

Preclinical Research

The strongest intervention evidence for Humanin comes from preclinical models. Studies have investigated neuroprotection, mitochondrial stress, metabolic regulation, cardiovascular injury, apoptosis and other cellular processes.

Animal research

Animal experiments have investigated Humanin and Humanin analogues in metabolic, cardiovascular, neurological and aging-related models.

Some studies report protective effects against experimental cellular or tissue injury. These findings are useful for hypothesis generation but do not establish human efficacy.

In-vitro research

Cell studies have examined Humanin's effects on apoptosis, oxidative stress, mitochondrial function and signaling pathways.

Results from cultured cells are particularly sensitive to experimental concentration, cell type, exposure duration and peptide preparation.

Do not extrapolate: A concentration that produces an effect in a cell-culture experiment is not a clinically validated concentration for humans.

Research Reconstitution & Humanin Concentration

For a research calculation, the basic concentration equation is:

Concentration = Total Vial Quantity ÷ Liquid Volume

Worked Example: 5 mg Humanin

Liquid Volume Calculation Resulting Concentration
1 mL 5 mg ÷ 1 mL 5 mg/mL
2 mL 5 mg ÷ 2 mL 2.5 mg/mL
2.5 mL 5 mg ÷ 2.5 mL 2 mg/mL
3 mL 5 mg ÷ 3 mL 1.67 mg/mL
5 mL 5 mg ÷ 5 mL 1 mg/mL

Worked Example: 10 mg Humanin

Liquid Volume Calculation Resulting Concentration
1 mL 10 mg ÷ 1 mL 10 mg/mL
2 mL 10 mg ÷ 2 mL 5 mg/mL
2.5 mL 10 mg ÷ 2.5 mL 4 mg/mL
3 mL 10 mg ÷ 3 mL 3.33 mg/mL
5 mL 10 mg ÷ 5 mL 2 mg/mL
Important: These calculations assume the stated peptide quantity and liquid volume are accurate. They do not establish that a particular volume is appropriate for a specific experimental protocol.

BAC Water vs. Humanin Concentration

BAC water is a liquid diluent. From a purely mathematical concentration perspective, changing the liquid volume changes the amount of peptide per milliliter.

More liquid

More liquid produces a lower concentration when the total peptide quantity remains fixed.

Example: 10 mg ÷ 5 mL = 2 mg/mL.

Less liquid

Less liquid produces a higher concentration when the total peptide quantity remains fixed.

Example: 10 mg ÷ 1 mL = 10 mg/mL.

Product-specific compatibility matters: Mathematical concentration does not establish that bacteriostatic water is an appropriate diluent for every Humanin preparation. Applicable manufacturer, laboratory, institutional or validated research instructions should take precedence.

Research Limitations & Safety

Humanin is an active area of mitochondrial-peptide research, but the evidence base should not be confused with an established therapeutic evidence base.

Evidence limitations

  • Many Humanin intervention studies are preclinical.
  • Human studies frequently evaluate endogenous Humanin as a biomarker rather than administer Humanin as a treatment.
  • Humanin analogues such as HNG should not automatically be treated as identical to native Humanin.
  • Experimental concentrations and animal doses cannot be directly converted into human therapeutic doses.
  • Peptide purity, identity, aggregation, formulation and storage can affect experimental results.

Regulatory context

The FDA's substance database contains a validated Humanin substance record, including the identifier H975EUX36G. A substance record should not be interpreted as FDA approval of a drug product or therapeutic indication.

No FDA-approved Humanin therapeutic indication was identified in the authoritative sources reviewed for this page.

Research-only distinction: BacScience does not establish or recommend a Humanin treatment dose. Mathematical reconstitution calculations, published experimental doses and FDA-approved drug dosages are separate concepts and must not be treated as interchangeable.

Explore Humanin Research Resources

BAC Water Calculator → Calculate concentration from custom vial quantities and liquid volumes. Research Compound Library → Browse additional research-compound educational resources. Peptide Research Library → Explore peptide mechanisms, evidence and research guides. Testing & Transparency → Review research on identity, purity, testing and documentation.

Frequently Asked Questions About Humanin Reconstitution

How much BAC water should be added to Humanin?
There is no universal scientifically established BAC-water volume for Humanin. The mathematical volume depends on the actual peptide quantity and the concentration required by a specific validated research protocol.
How much BAC water for 5 mg Humanin?
There is no universal recommended volume. Mathematically, 5 mg in 1 mL equals 5 mg/mL, 2 mL equals 2.5 mg/mL, 2.5 mL equals 2 mg/mL, 3 mL equals approximately 1.67 mg/mL, and 5 mL equals 1 mg/mL. These are calculations only.
How much BAC water for 10 mg Humanin?
As a mathematical example, 10 mg in 1 mL equals 10 mg/mL, 2 mL equals 5 mg/mL, 2.5 mL equals 4 mg/mL, 3 mL equals approximately 3.33 mg/mL, and 5 mL equals 2 mg/mL.
What is the Humanin concentration formula?
Concentration equals total peptide quantity divided by liquid volume. For example, 5 mg divided by 2 mL equals 2.5 mg/mL.
Does adding more BAC water lower Humanin concentration?
Yes, mathematically. If the total amount of Humanin remains fixed, increasing the liquid volume decreases the amount of peptide per milliliter.
Is Humanin FDA approved?
No FDA-approved Humanin therapeutic indication was identified in the authoritative sources reviewed for this page. FDA does maintain a validated substance record for Humanin, but a substance record is not equivalent to FDA approval.
Is Humanin the same as HNG?
No. HNG commonly refers to a potent Humanin analogue, often described as S14G-Humanin. An analogue should not automatically be treated as chemically or biologically identical to native Humanin.
Is there a clinically established Humanin dose?
No clinically established human therapeutic dose has been identified in the authoritative sources reviewed for this page. Human studies commonly involve endogenous Humanin measurements rather than therapeutic administration.
Can an animal Humanin dose be converted to a human dose?
No. Animal experimental doses cannot simply be converted into human treatment recommendations. Species, route, pharmacokinetics, formulation and biological response all affect interpretation.
Does a Humanin research dose determine how much BAC water to use?
No. Dose and concentration are different variables. A reported experimental dose does not automatically establish the reconstitution volume of a particular peptide vial.
Is 1 mg/mL a recommended Humanin concentration?
No. A 1 mg/mL result can be produced mathematically by placing 5 mg into 5 mL or 10 mg into 10 mL, but that mathematical result does not establish that 1 mg/mL is a validated Humanin research or clinical concentration.
Where can I calculate a different Humanin concentration?
Use the BacScience BAC Water Calculator to enter a custom vial quantity and liquid volume.

Scientific References

  1. Lee C, Yen K, Cohen P. Humanin: a harbinger of mitochondrial-derived peptides? Trends in Endocrinology & Metabolism. PMID: 23402768.
    PubMed record
  2. Abu Hazafa et al. Humanin: A mitochondrial-derived peptide in the treatment of apoptosis-related diseases. Life Sciences. PMID: 33130077.
    PubMed record
  3. Xiao J, Kim S-J, Cohen P, Yen K. Humanin: Functional Interfaces with IGF-I. Growth Hormone & IGF Research. PMID: 27082450.
    PubMed record
  4. Boutari C et al. Humanin and diabetes mellitus: A review of in vitro and in vivo studies. World Journal of Diabetes. PMID: 35432758.
    PubMed record
  5. Neuroprotective Action of Humanin and Humanin Analogues: Research Findings and Perspectives. PMID: 38132360.
    PubMed record
  6. The mitochondrial derived peptide humanin is a regulator of lifespan and healthspan. PMID: 32575074.
    PubMed record
  7. Humanin skeletal muscle protein levels increase after resistance training in men with impaired glucose metabolism. PMID: 27923980.
    PubMed record
  8. FDA Substance Registration: HUMANIN — UNII H975EUX36G.
    FDA GSRS substance record
  9. ClinicalTrials.gov: Humanin Isoforms in Cardiac Muscle and Blood Plasma and Major Complications After Cardiac Operation. NCT03431844.
    ClinicalTrials.gov record
  10. ClinicalTrials.gov: Clinical Value of Plasma Humanin in Acute Kidney Injury. NCT06105229.
    ClinicalTrials.gov record

Last Scientifically Reviewed

September 10, 2026
Scientific content review: BacScience Research Content Team
Regulatory review: FDA / ClinicalTrials.gov source checks
This page is educational and research-oriented and does not provide medical treatment or dosing instructions.